Alpha 2.0
Login Register
» Authors » Tatsuhiko Mori

Tatsuhiko Mori

Explore the profile of Tatsuhiko Mori including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 390
Followers 0
Related Specialties
Dermatology
Cardiology & Vascular Diseases
Pharmacology
Top 10 Co-Authors
Toshiyuki Yamamoto
Tetsuya Hayashi
Yasuo Matsumura
Yasushi Kitaura
Chika Yamashita
Yuka Hanami
Akira Ukimura
Kento Kitada
Mamoru Ohkita
Tomoko Hiraiwa
Published In
J Dermatol
Hypertens Res
An Bras Dermatol
Int J Dermatol
Circ J
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term control of giant primary acral melanoma without amputation surgery
Aitake U, Ishizuki S, Lei X, Izumi T, Koizumi S, Takai S, et al.
J Dermatol . 2024 May; 51(10):e354-e355. PMID: 38711283
No abstract available.
2.
Coexistence of pyoderma gangrenosum and cutaneous arteritis without systemic diseases
Yamamoto M, Watanabe Y, Mori T, Iwatsuki K, Chen K, Yamamoto T
J Dermatol . 2024 Feb; 51(7):e235-e236. PMID: 38345312
No abstract available.
3.
Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens
Koizumi S, Doi R, Aitake U, Lei X, Izumi T, Mori T, et al.
J Dermatol . 2024 Jan; 51(6):e203-e204. PMID: 38216840
No abstract available.
4.
Favorable efficacy of S-1 treatment for locoregionally advanced cutaneous squamous cell carcinoma in the head and neck region
Izumi T, Teramoto Y, Kamimura A, Doi R, Takai S, Mori T, et al.
J Dermatol . 2023 Nov; 51(2):271-279. PMID: 38009848
Cutaneous squamous cell carcinoma is usually treated with surgery; however, locoregionally advanced cutaneous squamous cell carcinoma can be difficult to resect. Although recent guidelines from Western countries recommend using anti-programmed...
5.
Adjuvant therapy for mucosal melanoma in the era of immune checkpoint inhibitors
Nakamura Y, Mori T
Chin Clin Oncol . 2023 Oct; 13(1):13. PMID: 37817508
No abstract available.
6.
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients
Mori T, Namikawa K, Yamazaki N, Kiniwa Y, Yamasaki O, Yoshikawa S, et al.
Front Med (Lausanne) . 2023 Aug; 10:1229937. PMID: 37636577
Background: Anti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1...
7.
Ulceration in Lupus Erythematosus Profundus Unassociated with Vasculitis: Report of Three Cases
Hanami Y, Mori T, Yamamoto T
Indian J Dermatol . 2023 Jun; 68(2):235. PMID: 37275802
No abstract available.
8.
Bullous pemphigoid developed after dramatic improvement of severe prurigo nodularis
Hiraiwa T, Matsumura N, Mori T, Kikuchi N, Yamamoto T
An Bras Dermatol . 2023 May; 98(5):689-691. PMID: 37225629
No abstract available.
9.
Six Cases of Erythrodermic Pemphigus Foliaceus: A Case Report
Norikawa N, Igari S, Ishikawa M, Mori T, Hiraiwa T, Kikuchi N, et al.
Case Rep Dermatol . 2023 Feb; 14(3):258-263. PMID: 36846101
Pemphigus foliaceus (PF) is one of the causes of erythroderma; however, to date, there have been relatively few reported cases. We herein describe 6 cases of erythrodermic PF. In all...
10.
A case of basal cell carcinoma arising in the umbilicus
Takada M, Mori T, Hanami Y, Yamamoto T
An Bras Dermatol . 2022 Dec; 98(2):243-244. PMID: 36567169
No abstract available.